Laurida Sayed - 02 May 2024 Form 3 Insider Report for Cushman & Wakefield plc (CWK)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
3
Accepted by SEC
08 May 2024, 16:53:02 UTC
Next SEC filing
25 Feb 2025
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Noelle J. Perkins, attorney-in-fact

Key filing fact

Laurida Sayed filed Form 3 for Cushman & Wakefield plc (CWK) on 08 May 2024.

Key facts

  • This page summarizes Laurida Sayed's Form 3 filing for Cushman & Wakefield plc (CWK).
  • 0 reported transactions and 3 derivative rows are listed below.
  • Accepted by SEC: 08 May 2024, 16:53.

Change

  • No earlier filing in this sequence is available for direct comparison.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Official SEC source

Ownership activity is grounded in SEC Form 3 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CWK holding

Ordinary Shares

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
5,159
Date
02 May 2024
Ownership
Direct

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

CWK holding Derivative

Restricted Stock Units

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
02 May 2024
Ownership
Direct
Underlying class
Ordinary Shares
Underlying amount
594
Exercise price
Footnotes
F1, F2
CWK holding Derivative

Restricted Stock Units

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
02 May 2024
Ownership
Direct
Underlying class
Ordinary Shares
Underlying amount
4,983
Exercise price
Footnotes
F2, F3
CWK holding Derivative

Restricted Stock Units

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
02 May 2024
Ownership
Direct
Underlying class
Ordinary Shares
Underlying amount
19,981
Exercise price
Footnotes
F2, F4
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 4 footnotes

Footnote F1

On February 24, 2022, the reporting person was granted 1,782 restricted stock units ("RSUs") which vest and settle in three equal installments on each of the first three anniversaries of the grant date, subject, with certain limited exceptions, to the reporting person's continuing employment through each such vesting date.

Footnote F2

RSUs were granted under the Amended & Restated Cushman & Wakefield plc 2018 Omnibus Management Share and Cash Incentive Plan and convert into an equal number of ordinary shares of Cushman & Wakefield plc.

Footnote F3

On February 23, 2023, the reporting person was granted 7,474 RSUs which vest and settle in three substantially equal installments on each of the first three anniversaries of the grant date, subject, with certain limited exceptions, to the reporting person's continuing employment through each such vesting date.

Footnote F4

On February 22, 2024, the reporting person was granted 19,981 RSUs which will vest and settle in three substantially equal installments on each of the first three anniversaries of the grant date, subject, with certain limited exceptions, to the reporting person's continuing employment through each such vesting date.

SEC remarks

Exhibit 24 - Power of Attorney

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .